Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF)

Mirko Farina, MD, Simona Bernardi, PhD, Nicola Polverelli, Camilla Zanaglio, PhD, Michele Malagola, MD, Federica Re, Federica Cattina, MD PhD, Mariella D'Adda, MD, Giuseppe Rossi, Tatiana Zollner, MD, Andrew Dunbar, MD, Ross L. Levine, MD, Domenico Russo, MD

Blood (2019) 134 (Supplement_1): 1684.

https://doi.org/10.1182/blood-2019-127451

Published: 2019

Journal Articles

Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach

Simona Bernardi, PhD, Camilla Zanaglio, PhD, Elif Dereli Eke, PhDStudent, Federica Cattina, MD PhD, Mirko Farina, MD, Stefania Masneri, PhD, Benedetta Rambaldi, MD, Francesca Schieppati, MD, Alessandro Turra, MD, Nicola Polverelli, MD, Enrico Morello, MD, Michele Malagola, MD, Domenico Russo, MD

Blood (2018) 132 (Supplement 1): 4387.

https://doi.org/10.1182/blood-2018-99-109927

Published: 2018

Journal Articles

ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience

Blood (2018) 132 (Supplement 1): 3381.

https://doi.org/10.1182/blood-2018-99-110252

Published: 2018

Journal Articles

Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR 4.0 , MR 4.5 And MR 5.0 ) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR)

Blood (2016) 128 (22): 3096.

https://doi.org/10.1182/blood.V128.22.3096.3096

Published: 2016

Journal Articles

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Benedetta Rambaldi, MD, Michele Malagola, MD PhD, Giuseppe Ravizzola, MD, Giorgio Giannetta, Nicola Polverelli, MD PhDstudent, Cristina Skert, MD, Alessandro Turra, MD, Valeria Cancelli, MD, Federica Cattina, MD PhD, Francesca Schieppati, MD, Arnaldo Caruso, MD, Domenico Russo, MD

Blood (2016) 128 (22): 2223.

https://doi.org/10.1182/blood.V128.22.2223.2223

Published: 2016

Journal Articles

Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients

Nicola Polverelli, MD PhDstudent, Michele Malagola, MD PhD, Alessandro Turra, MD, Cristina Skert, MD, Federica Cattina, MD PhD, Benedetta Rambaldi, MD, Rossella Ribolla, MD, Valeria Cancelli, MD, Francesca Schieppati, MD, Marta Bonetti, MD, Simona Bernardi, PhD, Simone Perucca, PhD, Camilla Zanaglio, Domenico Russo, MD

Blood (2016) 128 (22): 4601.

https://doi.org/10.1182/blood.V128.22.4601.4601

Published: 2016

Journal Articles

A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs)

Simona Bernardi, Federica Cattina, Andrea Di Palma, Erika Borlenghi, MD, Francesca Schieppati, Simone Perucca, Valeria Cancelli, Alessandro Turra, Michele Malagola, Crisitina Skert, Carla Filì, Chiara Cattaneo, MD, Angela Passi, Mirko Farina, Giuseppe Rossi, MD, Flavio Mignone, Domenico Russo

Blood (2015) 126 (23): 4952.

https://doi.org/10.1182/blood.V126.23.4952.4952

Published: 2015

Journal Articles

Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR 3.0 ) or DEEP (MR 4.0 , MR 4.5 and MR 5.0 ) Molecular Response with Tyrosin Kynase Inhibitors (TKIs)

Simona Bernardi, Andrea Di Palma, Mario Tiribelli, MD, Erika Codarin, Giuseppina Ruggeri, Maria Teresa Bochicchio, Michele Malagola, Federica Cattina, Simone Perucca, Valeria Cancelli, Crisitina Skert, Gianantonio Rosti, MD, Fausto Castagnetti, PhD, Luigi Caimi, Giuseppe Rossi, Giovanni Martinelli, Domenico Russo

Blood (2015) 126 (23): 4028.

https://doi.org/10.1182/blood.V126.23.4028.4028

Published: 2015

Journal Articles

Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse

Crisitina Skert, Simone Perucca, Imberti Luisa, Chiarini Marco, Michele Malagola, Carla Filì, Viviana Giustini, MSC, Claudia Ghidini, BSC, Federica Cattina, Alessandro Turra, Valeria Cancelli, Simona Bernardi, Domenico Russo

Blood (2015) 126 (23): 3150.

https://doi.org/10.1182/blood.V126.23.3150.3150

Published: 2015

Journal Articles

Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease

Cristina Skert, MD, Alessandro Turra, Michele Malagola, Simone Perucca, Valeria Cancelli, Rosa Daffini, Rossella Ribolla, Cesare Bergonzi, Carla Filì, MD, Chiara Pagani, MD, Andrea Di Palma, Federica Cattina, MD PhD, Simona Bernardi, Domenico Russo, MD PhD

Blood (2014) 124 (21): 3932.

https://doi.org/10.1182/blood.V124.21.3932.3932

Published: 2014

Journal Articles

Patterns of Lymphocyte Subsets and Index of Bone Marrow Output (KRECs) Correlate Differently with Graft-Versus-Host Disease and Relapse

Cristina Skert, MD, Simone Perucca, Luisa Imberti, Marco Chiarini, MSc, Michele Malagola, Carla Filì, MD, Cesare Bergonzi, Rossella Ribolla, Valeria Cancelli, Alessandro Turra, Federica Cattina, MD PhD, Andrea Di Palma, Domenico Russo, MD PhD

Blood (2014) 124 (21): 3933.

https://doi.org/10.1182/blood.V124.21.3933.3933

Published: 2014

Journal Articles

SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients

Blood (2014) 124 (21): 1030.

https://doi.org/10.1182/blood.V124.21.1030.1030

Published: 2014

Journal Articles

Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients

Elisa Zuffa, PhD, Eugenia Franchini, Cristina Papayannidis, MD PhD, Carmen Baldazzi, PhD, Nicoletta Testoni, PhD, Federica Cattina, MD PhD, Maria Chiara Abbenante, Stefania Paolini, Ilaria Iacobucci, PhD, Viviana Guadagnuolo, Antonella Padella, Giorgia Simonetti, PhD, Emanuela Ottaviani, Giovanni Martinelli, MD

Blood (2014) 124 (21): 1040.

https://doi.org/10.1182/blood.V124.21.1040.1040

Published: 2014

Journal Articles

WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia

Michele Malagola, Crisitina Skert, Enrico Morello, MD, Francesca Antoniazzi, MD, Erika Borlenghi, MD, Alessandro Turra, Chiara Pagani, MD, Rossella Ribolla, Valeria Cancelli, Federica Cattina, MD PhD, Elisa Alghisi, Simona Bernardi, Simone Perucca, Andrea Di Palma, Giuseppina Ruggeri, Giuseppe Rossi, Luigi Caimi, Domenico Russo, MD

Blood (2014) 124 (21): 3695.

https://doi.org/10.1182/blood.V124.21.3695.3695

Published: 2014

Journal Articles

Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis

Blood (2013) 122 (21): 2622.

https://doi.org/10.1182/blood.V122.21.2622.2622

Published: 2013

Journal Articles

Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

Blood (2013) 122 (9): 1634–1648.

https://doi.org/10.1182/blood-2013-03-487728

Published: 2013

Includes: Supplemental data

Journal Articles

In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL)

Ilaria Iacobucci, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, Enrico Derenzini, MD, Anna Ferrari, Cristina Papayannidis, Claudia Venturi, Annalisa Lonetti, Viviana Guadagnuolo, Federica Cattina, Emanuela Ottaviani, Maria Chiara Abbenante, Domenico Russo, Michele Baccarani, MD, Pier Giuseppe Pelicci, Giovanni Martinelli, MD

Blood (2012) 120 (21): 1496.

https://doi.org/10.1182/blood.V120.21.1496.1496

Published: 2012

Journal Articles

Loss of Heterozygosity At the C Wild-Type Allele of rs1042522 in the TP53 Gene Frequently Occurs During Progression of Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL).

Blood (2012) 120 (21): 2497.

https://doi.org/10.1182/blood.V120.21.2497.2497

Published: 2012

Journal Articles

Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia.

Ilaria Iacobucci, Daniela Erriquez, Anna Ferrari, Cristina Papayannidis, Claudia Venturi, Stefania Trino, Viviana Guadagnuolo, Annalisa Lonetti, Federica Cattina, Emanuela Ottaviani, Maria Chiara Abbenante, Sarah Parisi, Simona Soverini, Domenico Russo, Fabrizio Pane, Michele Baccarani, MD, Giovanni Perini, Giovanni Martinelli

Blood (2012) 120 (21): 2522.

https://doi.org/10.1182/blood.V120.21.2522.2522

Published: 2012

Journal Articles

Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies

Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Cristina Papayannidis, Paola Bresciani, Valeria Coluccio, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Federica Cattina, Robin Foà, MD, Antonella Vitale, Domenico Russo, Michele Baccarani, MD, Giovanni Martinelli

Blood (2012) 120 (21): 284.

https://doi.org/10.1182/blood.V120.21.284.284

Published: 2012

NARROW

Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF)

Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach

ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience

Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR 4.0 , MR 4.5 And MR 5.0 ) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR)

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients

A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs)

Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse

Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease

Patterns of Lymphocyte Subsets and Index of Bone Marrow Output (KRECs) Correlate Differently with Graft-Versus-Host Disease and Relapse

SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients

Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients

WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia

Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis

Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL)

Loss of Heterozygosity At the C Wild-Type Allele of rs1042522 in the TP53 Gene Frequently Occurs During Progression of Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL).

Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia.

Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only